Podcasts about respiratory

Angioedema – Recognition and Management in the ED Hosts: Maria Mulligan-Buckmiller, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Angioedema.mp3 Download Leave a Comment Tags: Airway Show Notes Definition & Pathophysiology Angioedema = localized swelling of mucous membranes and subcutaneous tissues due to increased vascular permeability. Triggers increased vascular permeability → fluid shifts into tissues. Etiologies Histamine-mediated (anaphylaxis) Associated with urticaria/hives, pruritus, and redness. Triggered by allergens (foods, insect stings, medications). Rapid onset (minutes to hours). Bradykinin-mediated Hereditary angioedema (HAE): C1 esterase inhibitor deficiency (autosomal dominant). Acquired angioedema: Associated with B-cell lymphoma, autoimmune disease, MGUS. Medication-induced: Most commonly ACE inhibitors; rarely ARBs. Typically lacks urticaria and itching. Gradual onset, can last days if untreated. Idiopathic angioedema Unknown cause; diagnosis of exclusion. Clinical Presentations Swelling Asymmetric, non-pitting, usually non-painful. May involve lips, tongue, face, extremities, GI tract. Respiratory compromise Upper airway swelling → stridor, dyspnea, sensation of throat closure. Airway obstruction is the most feared complication. Abdominal manifestations

The Immune team goes up the nose to discuss cytotoxic T cells activating complement through secretion of granzyme K to drive inflammatory nasal polyps and how IgA-producing B cells are made in the nose. Hosts: Vincent Racaniello, Cindy Leifer, Steph Langel, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of Immune! Links for this episode MicrobeTV Discord Server CD8 T cells in recurrent airway inflammation (Nature 2025) Where IgA producing B cells arise that protect the nose (Nature 2024) Time stamps by Jolene Ramsey. Thanks! Music by Tatami. Immune logo image by Blausen Medical Send your immunology questions and comments to immune@microbe.tv Information on this podcast should not be construed as medical advice.  

In this episode, we review the high-yield topic of⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Pneumonia ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Respiratory section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

In this episode, we review the high-yield topic of⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Sleep Apnea⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Respiratory section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

Episode 150 - Pacing Strategies, Emerging Emphasis on Respiratory Rate, and 6h Racing on 6h Training   Hello everyone. Welcome to the latest episode of The Matchbox Podcast powered by Ignition Coach Co. I'm your host, Adam Saban, and on this week's episode we're talking pacing strategies for longer races, the emergence of respiratory rate in endurance sports science, and how to train for 100mi gravel events with less than 6 hours per week to train.   As always, if you like what you hear please share this with your friends and leave us a five star review and if you have any questions for the show drop us an email at matchboxpod@gmail.com with the topic of discussion in the email title or head over to ignitioncoachco.com and fill out The Matchbox Podcast listener question form. You can also sign up for the Matchbox Patreon and get priority placement for your submitted questions.   Alight let's get into it!   For more social media content, follow along @ignitioncoachco @adamsaban6 @dizzle_dillman @dylanjawnson @kait.maddox     https://patreon.com/MatchboxPodcast?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink   https://www.youtube.com/c/DylanJohnsonCycling https://www.ignitioncoachco.com  https://www.youtube.com/@DrewDillmanChannel   Intro/ Outro music by AlexGrohl - song "King Around Here" - https://pixabay.com/music/id-15045/    The following was generated using Riverside.fm AI technologies   Summary In this episode, the hosts recap their recent training camp in Crested Butte, discussing the camaraderie and coaching experiences. They delve into pacing strategies for endurance races, emphasizing the importance of understanding personal fitness levels and race dynamics. The conversation shifts to the emerging significance of respiratory rates as a performance metric, highlighting its reliability compared to heart rate. Finally, they provide insights on training for gravel races, particularly for those with limited time, stressing the need for familiarity with race distances to ensure successful outcomes.   Chapters 00:00 Crested Butte Training Camp Recap 02:20 Pacing Strategies for Endurance Races 14:52 Understanding Respiratory Rates in Performance 22:58 Training Structure for Gravel Racing  

Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. Today, we're focusing on an often-overlooked peptide called VIP, short for Vasoactive Intestinal Peptide. The name might sound technical, but this peptide plays some important roles in the body. It helps regulate inflammation, supports nerve function, improves blood flow by relaxing blood vessels, and may even have benefits for things like chronic pain, including back pain. Let's get into it. What is VIP? We've talked about VIP before on a previous podcast, but it's been awhile and I'd like to start with the basics as a refresher.  VIP is a 28-amino acid neuropeptide that acts like a signaling molecule in both the central and peripheral nervous systems. Think of it like a chemical messenger that can influence a lot of different body systems. VIP belongs to the glucagon/secretin peptide superfamily, and it's found throughout the body, including your brain, intestines, lungs, and immune cells. Now, what does VIP actually do? Well it does quite a bit. VIP works by binding to specific receptors on cells—called VPAC1 and VPAC2—which trigger a chain reaction inside the body through something known as the cyclic AMP pathway. Once activated:  It relaxes smooth muscles, which helps open up blood vessels (vasodilation) and airways (bronchodilation) It stimulates secretion of water and electrolytes in places like the gut and pancreas—so yes, it helps with digestion too It's a major immune modulator, calming inflammation by regulating immune cell behavior  Neuroprotective role, supporting the survival and adaptability of neurons VIP in Medicine – What's the Buzz? VIP has been studied in a variety of conditions. Inflammatory diseases like rheumatoid arthritis and Crohn's Neurodegenerative conditions like Alzheimer's and Parkinson's Autoimmune diseases like osteoarthritis Respiratory conditions like pulmonary arterial hypertension (PAH), asthma, and chronic obstructive pulmonary disease (COPD) or due to mold toxicity But today, we're zooming in on something more tangible for a lot of people—back pain. VIP and Back Pain – What Do We Know? Let's get into the science here. VIP has recently caught attention for its potential role in intervertebral disc degeneration, which is one of the top causes of chronic low back pain. A 2024 study found that VIP receptors were significantly reduced in degenerated human discs—which is kind of a red flag. When VIP was given to mice for four weeks, researchers saw slowed degeneration, better structural proteins like aggrecan, and overall healthier discs on imaging. Promising, right? But here's the catch—this was a preclinical animal study. We still need human trials to confirm it works outside the lab. VIP and Joint Pain And when it comes to VIP and joint pain, there's a bit more research on VIP and osteoarthritis, especially when the spine is involved. In OA models, VIP was shown to lower pro-inflammatory cytokines—those molecules that contribute to pain and make joints hurt. But here's where it gets complicated: some studies report that VIP accumulation in joints might actually worsen pain. So... it's a bit of a paradox. So what's the takeaway? VIP can be helpful—but its role in pain management seems to depend on how much, where, and what kind of pain we're talking about. VIP in Peptide Therapy – Real-World Use? In peptide clinics—especially those using integrative or regenerative medicine approaches—VIP is sometimes part of treatment protocols for nerve-related pain and inflammation. It's often paired with other peptides like BPC-157 and TB-500. You can find some clinics that list VIP as a go-to for chronic pain, including back pain. But here's the reality check, clinical data is limited, success is anecdotal, it's pricey and results can vary from person to person. So while VIP might help reduce inflammation and slow tissue degeneration, it's not a substitute for tried-and-true pain management peptides like BPC-157. Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Until next time, be well, and as always, have a happy, healthy week.

In this episode of Health Matters we discuss how to breathe easier this summer with Dr. Kalliope Tsirilakis, a pediatric pulmonologist at NewYork-Presbyterian and Weill Cornell Medicine. She explains why heat and wildfires make air quality worse in the summer, and shares tips on how to protect lung health.___Kalliope Tsirilakis, M.D. is the director of pediatric pulmonology and the Pediatric Asthma Center at NewYork-Presbyterian Queens. She is also an assistant attending pediatrician at NewYork-Presbyterian Komansky Children's Hospital and an assistant professor of clinical pediatrics at Weill Cornell Medicine. A lifelong New Yorker, born in Brooklyn and raised in Westchester, she graduated from Weill Cornell Medicine and completed her residency in pediatrics at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Tsirilakis continued her training at the Children's Hospital at Montefiore in the Bronx, where she completed a fellowship in pediatric respiratory medicine. She is board certified in pediatrics and pediatric pulmonology. Her expertise includes the full spectrum of pediatric pulmonary conditions, with special expertise in severe asthma, patient education, quality improvement, flexible bronchoscopy, and aerodigestive disorders.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

On episode #85 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 7/3 – 7/21/25. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Elimination of HIV Reservoirs Harboring Intact Proviruses (JID) Bacterial Expansion of tetM-Carrying Neisseria gonorrhoeae in the United States, 2018–2024 (NEJM) Study hints doxyPEP use coincides with rise in tetracycline-resistant gonorrhea in US (CIDRAP) Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization With Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus (CID) Methenamine hippurate asprophylaxis for recurrent urinary tract infections in older women – a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU). (CMI: Clinical Microbiology and Infection) Diagnosis and Management ofCommunity-acquired Pneumonia(American Journal of Respiratory and Critical Care Medicine) Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management (IDSA) The impact of an intervention to increase follow-up blood cultures for patients with Staphylococcus aureus bacteriuria (Antimicrobial Stewardship & Healthcare Epidemiology) Fungal The Last of US Season 2 (YouTube) Candida auris Containment Responses in Health Care Facilities that Provide Hemodialysis Services (CDC: MMWR) Candidozyma auris: an emerging threat (Reflections on Infectious Prevention and Control) Effects of postoperative antifungal therapy on the recurrence of Aspergillus infection after pulmonary aspergilloma resection (BMC Infectious Diseases) Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study (LANCET: Microbe) Large language models and their performance for the diagnosis of histoplasmosis (PLoS Neglected Tropical Diseases) Parasitic Field evidence of Trypanosoma cruzi infection, diverse host use and invasion of human dwellings by the Chagas disease vector in Florida, USA (PLoS Neglected Tropical Diseases) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

 The Supplemental Oxygen Access Reform Act (SOAR Act) is a piece of pending legislation establishes certain requirements with respect to the payment and provision of supplemental oxygen and related services under Medicare. But how would this legislation affect patients, and how is the ATS Nursing Assembly leading the charge in advocating for their needs? Host Patti Tripathi explores this question, and more, with Susan Jacobs, RN, MS, research nurse manager at Stanford University; and Jaeger Spratt, MSW, advocacy and treatment access program manager at the Pulmonary Hypertension Association. This episode is the first in a two-part series collaboration with the Pulmonary Hypertension Association podcast, PH Insights. The Pulmonary Hypertension Association Advocacy Action Center: https://phassociation.org/advocate/ Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlights Package. Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

   Command Sergeant Major Gabriel Wright shares his extraordinary journey from serving with the Army Rangers to becoming a senior respiratory therapist in military medicine. His transformation was profoundly influenced by the events of 9-11, leading to deployments in Afghanistan and Iraq, where he faced the harsh realities of combat head-on. With passion and earnestness, CSM Wright reveals the demanding Ranger selection process and the specialized training that shaped his initial military career. He also imparts invaluable advice for enlisted soldiers eager to pivot into medical careers, stressing the pivotal role mentorship plays in their professional development.   Listeners will gain an intimate look into the life of a respiratory therapist in combat zones as CSM Wright recounts his deployment with the 31st Combat Support Hospital at Camp Dwyer, Afghanistan. The challenges were immense, from managing polytrauma and blast injuries to setting up a hospital with scant resources. Yet, through teamwork and adaptability, CSM Wright demonstrates how the critical task of managing airways and ensuring patient stabilization was successfully accomplished. His stories of resilience and education underscore the formidable training and coordination necessary for effective patient care and evacuation in such environments.    The episode further explores the collaborative spirit of military medicine through CSM Wright's 2015 deployment to Iraq. Here, the focus is on teamwork across various military branches and international partners, all working together to achieve a common life-saving goal. CSM Wright shares his insights on the evolving landscape of medical logistics, emphasizing the importance of interoperability and the Global Combat Support System-Army. Through discussions on leadership and mentorship, he reflects on the empowering effects of guiding soldiers and fostering an environment of trust. The profound impact of leadership on both personal and professional landscapes is woven throughout his narrative, offering listeners a comprehensive understanding of a military career marked by dedication and transformation.   Chapters: (00:04) Military Medicine Journey and Mentorship (11:33) Combat Hospital Respiratory Therapist Duties (22:59) Military Medical Collaboration and Mission Success (34:56) Medical Logistics and Career Development (44:44) Leadership and Mentorship in Military Medicine   Chapter Summaries: (00:04) Military Medicine Journey and Mentorship   CSM Gabriel Wright's journey from the Ranger Regiment to Army Respiratory Therapist, deployment experiences, and advice for enlisted soldiers pursuing medical careers.   (11:33) Combat Hospital Respiratory Therapist Duties CSM Gabriel Wright's RT experiences in a military setting, managing airways and stabilizing patients with limited resources.   (22:59) Military Medical Collaboration and Mission Success CSM Gabriel Wright's RT skills play a critical role in managing airways during a 2015 deployment to Iraq with the 10th CSH, while first sergeants must rapidly assemble surgical teams for deployment to Egypt.   (34:56) Medical Logistics and Career Development   Army's medical logistics transition to GCSS-Army for efficient management, interoperability, career pathways, and mentorship for enlisted soldiers.   (44:44) Leadership and Mentorship in Military Medicine    Leadership and mentorship in the military, empowering soldiers, cross-training, and personal impact and fulfillment.     Take Home Messages: Transitioning Careers in the Military: The episode highlights the potential for military personnel to pivot into different career paths within the military, such as transitioning from combat roles to medical professions. It emphasizes the importance of mentorship and guidance in facilitating these transitions, offering insights and advice for those interested in pursuing medical careers. Resilience and Adaptability in Combat Medicine: The discussion underscores the critical role of respiratory therapists in combat zones, dealing with severe injuries like polytrauma and blast injuries. It highlights the immense challenges faced, such as setting up medical facilities with limited resources, and the importance of teamwork and adaptability in ensuring effective patient care and stabilization. Collaboration Across Military and International Teams: The episode explores the collaborative spirit necessary for successful military medical operations, detailing how various military branches and international partners work together towards life-saving goals. The importance of understanding different cultures, missions, and communication styles is emphasized to achieve mission success Evolving Medical Logistics and Interoperability: A key takeaway is the evolving landscape of military medical logistics, with a focus on transitioning to more efficient systems like the Global Combat Support System-Army. The importance of interoperability among coalition partners and military services is highlighted to maintain a ready and effective medical force. Impact of Leadership and Mentorship: The episode delves into the profound impact of leadership and mentorship within military medicine. It emphasizes how empowering soldiers, fostering an environment of trust, and providing clear guidance can lead to successful outcomes. The personal and professional growth derived from effective leadership is a central theme throughout the narrative.   Episode Keywords: Military medicine, Army Rangers, Combat medic, Gabriel Wright, Resilience, Leadership, Mentorship, Battlefield care, Combat support hospital, Afghanistan deployment, Iraq deployment, Respiratory therapist, Military logistics, Interoperability, Teamwork, Medical career advice, Patient stabilization, Airway management, Global Combat Support System-Army, War Docs podcast, Military healthcare journey    Hashtags: #MilitaryMedicine #ArmyRanger #CombatMedic #ResilienceInBattle #LeadershipInHealthcare #BattlefieldMentorship #CombatSupport #RespiratoryTherapy #TeamworkInCombat #WarDocsPodcast    HOW TO WATCH Check out the full episode featuring CSM Wright on our YouTube channel: https://youtu.be/NL5rxJFtcM8   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast      

At the 2025 ATS International Conference, Joshua Fessel, MD, PhD, ATSF, formerly of the NIH, and Shade Afolabi, MD, a pediatric pulmonologist practicing in Texas, sat down to discuss the extensive ramifications the cuts to the NIH caused researchers, clinicians, and patients. With host Erika Moseson, MD, MA, they explore the effects of losing funding on critical research projects, how patient families have been dealing with pauses on disease research, and how the field can help retain and support early career professionals affected by these policy decisions. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

You know those cases where things just don't add up? In this episode, we break down a pediatric respiratory case that started out like routine asthma, but something didn't sit right. Tune in as we walk through the red flags, physical exam clues, and how one small detail changed everything. Perfect for nurse practitioners looking to sharpen their clinical reasoning and differential diagnosis in pediatric primary care.Check out Picmonic: https://www.picmonic.comCheck out our eBooks designed specifically for NP students navigating the clinical setting!⁠⁠⁠ ⁠⁠⁠⁠⁠https://bit.ly/SuccessNPebook⁠⁠⁠⁠Follow us on instagram:⁠ ⁠⁠ ⁠@thesuccesnp⁠⁠⁠⁠Go to our website⁠ ⁠⁠www.successnps.com⁠⁠

 On this episode of the ATS Breathe Easy podcast, meet the newly-elected ATS President, Raed Dweik, MD, MBA, ATSF. Host Amy Attaway, MD, MS, talks with Dr. Dweik on his vision for the ATS, and what he is most excited for in the fields of respiratory health, critical care, and how the ATS is braced to help members face ongoing challenges. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

About this episode: Asthma can cause sometimes debilitating symptoms for children who have it, and some—particularly Black and Hispanic children—can experience higher rates of diagnoses, hospitalizations and emergency department visits. In this episode: pediatrician and immunology researcher Dr. Elizabeth Matsui talks about the known causes behind childhood asthma and how it impacts youths, and how factors like poor housing conditions and barriers to care and medication worsen conditions and undermine long-term lung development. Guest: Dr. Elizabeth Matsui is a pediatric allergist-immunologist and epidemiologist and a leading researcher on the connection between asthma and environmental conditions. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: The Role of Neighborhood Air Pollution in Disparate Racial and Ethnic Asthma Acute Care Use—American Journal of Respiratory and Critical Care Medicine Association of a Housing Mobility Program With Childhood Asthma Symptoms and Exacerbations—JAMA Do upper respiratory viruses contribute to racial and ethnic disparities in emergency department visits for asthma?—The Journal of Allergy and Clinical Immunology Tackling Housing Injustice—and Improving Childhood Asthma—Public Health On Call (June 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University

In this episode, Craig Douglas, SVP of HME, Respiratory, & Wellness at VGM, is joined by Melanie Ewald, VP of Payer Relations and Reimbursement, and Kim Cuce', Director of Business Optimization, to tackle one of the biggest challenges in the HME industry: closed payer networks. They share practical strategies for navigating out-of-network situations, working with third-party administrators, and pursuing single case agreements, while emphasizing the importance of clear patient communication, understanding reimbursement, and knowing, understanding, and keeping copies of your contracts.

We examine efforts to prevent the spread of resporitory viruses in America's jails and prisons and what practices were identified from this experience.    Guest Biographies NhuNgoc Pham is a research scientist with CNA's Center for Public Health Preparedness and Resilience. Jim Alexander is a senior advisor with CNA's Center for Justice Research and Innovation. Darren Sieger is the Director of the Administration Broward Sheriff's Office and has helped correctional facilities implement steps to mitigate respiratory viruses. Further Reading Bueru of Justice Assitance: Planning for Respiratory Pathogen Pandemics A Guidebook for Corrections Systems and Confinement Facilities  

On this edition of the ATS Breathe Easy: The Latest, host Patti Tripathi and Foundation for Sarcoidosis Research President and CEO Mary McGowan discuss sarcoidosis research and the Champions for Change movement to encourage companies to allow employees to use paid time off to enroll in clinical trials. To learn more, go to ignorenomore.org. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

Substack is where I discovered Dr. MeiLan Han! I was browsing through and was pleasantly surprised to read an article, and learn that she wrote a book called, Breathing Lessons. And to top it off, she's from my home state of Michigan. I also learned the Dr. Han's book was “a passion project during the pandemic.”I'm delighted to share a conversation with Dr. MeiLan Han, one of the country's most respected voices in lung health and a tireless advocate for people living with chronic respiratory conditions.Dr. Han is a Professor of Medicine and Chief of Pulmonary and Critical Care at University of Michigan Health. She's not only cared for patients at the bedside but has devoted her career to understanding lung disease at its roots, with a special focus on chronic obstructive pulmonary disease (COPD), a condition that remains widely under-recognized and underfunded. Through her research, Dr. Han is helping to uncover how diseases like COPD affect the lungs in different ways, with the goal of making treatment more precise, more effective, and more personalized.Her journey began at the University of Washington and continued through specialized training at the University of Michigan, where she also earned a Master's degree in Biostatistics and Clinical Study Design. Today, she leads research funded by the National Institutes of Health (NIH), serves on national advisory boards for the COPD Foundation and the American Lung Association, and contributes to global guidelines that shape how lung disease is diagnosed and treated.Dr. Han also serves as Deputy Editor of the American Journal of Respiratory and Critical Care Medicine, helping to guide the direction of clinical practice and research in pulmonary medicine.If you or someone you love is living with a chronic lung condition, Dr. Han's insight is not only encouraging, it's essential. I'm so grateful to bring her voice to this platform. How many breathes do we take in a lifetime? It's fascinating to discuss and you'll hear the answer in our podcast.Lung health, do you think about it?To get her book: https://www.amazon.com/Breathing-Lessons-Doctors-Guide-Health-ebook/dp/B08X2ZFGNZ/ref=tmm_kin_swatch_0 Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Hauled off airplane for fatness?... Alligator Alcatraz?... McDonalds and Krispy Kreme divorcing…. Diddy Trial still on…. Apology for Not using No Crying…. PayPal makes deal with college conferences... Email: ChewingTheFat@theblaze.com   www.blazetv.com/jeffy  Promo code Jeffy…. Starbucks changes syrup pricing…. Apple and F1…. Schumer rushed to hospital…. How did they die?... Anne Burell possible OD at 55 / Brian Wilson 82 Respiratory arrest – many contributing factors…. Anna Wintour 37 years at Vogue Stepping down as Editor-in-Chief…. Faith Kipyegon beats her World Record mile time…. Game Show: What's The Lie? Contestant: Kent Reagan…   Learn more about your ad choices. Visit megaphone.fm/adchoices

 In our continuing series on What You May Have Missed at ATS 2025, Sunil Kapoor, MD, Medical College of Georgia, and host Erika Moseson, MD, MA, of the Air Health Our Heath podcast, discuss their takeaways from the "Strategies to Reduce Pulmonary and Critical Care Practice Emissions" networking event at ATS 2025. This includes how practices can reduce their carbon footprint and how better climate change policies can help patient outcomes. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package.Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

Sharon Samjitsingh is an asthma patient and developer of the ADAMM wearable device and Nightingale emergency respiratory care services. She has suffered with asthma her entire life and as a child, fear surrounded her and her family never knowing when the next attack would occur. As an adult she decided to do something to help others monitoring their breathing rhythms, heart rate and symptoms by developing a wearable technology that is taped under the torso and data relayed to a smartphone or computer via wifi that send alerts of an upcoming attack far in advance of its presentation. Her team of on call respiratory therapists then coach the patient with breathing education and behavior modification to reduce likelihood of presentation of an attack. Her results have changed the life of an asthma, COPD, ILD, and Cystic Fibrosis patient from a life caged by fear to one of empowering freedom and self-control. For review of the studies, visit healthcareoriginals.com

Episode 69: The Hidden Harms of Vaping and Nicotine Pouches - What Dental Professionals Need to Know Hosts: Tabitha Acret (Australia) & Melissa Obrotka (USA)  Episode Description  In this critical episode, Tabitha and Melissa tackle one of the most pressing and misunderstood topics in oral health today: the harms of vaping and nicotine pouches like Zyn. Far from being "harmless alternatives," these products present significant risks that dental professionals need to understand and address. Key Topics Covered What Are Vapes and Nicotine Pouches?

Brent Fikowski, Kyle Ruth, Luke Way and Dr. Andrew Sellars join the show to discuss the Isocapnic Breathe Way Better device.» Breathe Way Better Interview with Kyle Ruth: https://www.youtube.com/watch?v=uhr1u23gw20&t» Brent Echo / Snatch Workout: https://www.youtube.com/watch?v=wVI_A551tn8&pp=ygUaZWNobyBzbmF0Y2ggY3Jvc3NmaXQgZ2FtZXM%3D» Climbing Snail Workout: https://www.youtube.com/watch?v=J5r-sUwer_E&t=6305s» Watch on YouTube: https://youtu.be/KMt5Hjf7zjY» View All Episodes: https://zoarfitness.com/podcast/» Hire a Coach: https://www.zoarfitness.com/coach/» Follow ZOAR Fitness on Instagram: https://www.instagram.com/zoarfitness/Support the show

 This week, in our series on What You May Have Missed at ATS 2025, host Eddie Qian, MD, of the Vanderbilt University Medical Center, discusses post intensive care syndrome with Justin Banerdt, MD, MPH, Vanderbilt University Medical Center. Dr. Banerdt presented his research on the subject, “Characterizing Critical Illness Recovery Trajectories: Exploring Risk Factors for Post Intensive Care Syndrome”, at ATS 2025 this past May. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. Be sure to check out the Out of the Blue podcast from the American Journal of Respiratory and Critical Care Medicine, which takes you out of the pages of the Blue Journal and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine. Tune in wherever you listen to podcasts! 

Respiratory syncytial virus, or RSV, is a common and highly contagious virus that can affect the nose, throat and lungs. Nearly all Australian infants will catch RSV before age two, and while many cases are mild, the virus can cause severe illness - particularly in babies and young children. Now, a new free maternal vaccine has been added to the National Immunisation Program, offering free protection for newborns. In this episode of The Briefing, in partnership with the Australian Government, Sacha Barbour Gatt speaks with paediatric infectious disease physician Dr Linny Phong about the virus, the RSV maternal vaccine and how it could help safeguard Australian families. Follow The Briefing: TikTok: @listnrnewsroom Instagram: @listnrnewsroom @thebriefingpodcast YouTube: @LiSTNRnewsroom Facebook: @LiSTNR NewsroomSee omnystudio.com/listener for privacy information.

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Continuing our series on What You May Have Missed at ATS 2025, host Amy Attaway, MD, MS, of Cleveland Clinic, dives into key topics from the Clinical Year in Review with Sara Auld, MD, MSc, Emory University. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. 

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Episode 193: Gestational Diabetes IntroJesica Mendoza (OMSIII) describes the pathophysiology of gestational diabetes and the right timing and method of screening for it. Dr. Arreaza adds insight into the need for culturally-appropriate foods, such as vegetables in Mexican cuisine.    Written by Jesica Mendoza, OMSIII, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. Editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.DefinitionGestational diabetes mellitus (GDM) is a condition that occurs to previously non-diabetic pregnant women, caused by glucose intolerance at around the 24th week of gestation. PathophysiologyGDM arises due to an underlying pancreatic beta cell dysfunction in the mother which leads to a decrease in the amount of insulin produced and thus leads to higher blood sugar levels during pregnancy. The placenta of the fetus will produce hPL (human placental lactogen) to ensure a steady supply of sugars to the fetus, creating an anti-insulin effect. However, hPL readily crosses the placental barrier causing the mothers insulin requirement to increase, when the mother's pancreas cannot increase production of insulin to that level needed to counter the effect of hPL they become diabetic, and this leads to gestational diabetes. So, basically the placenta is asking for more glucose for the baby and the mother's pancreas struggles to keep the glucose level within normal limits in the body of the mother. If left untreated, high levels of glucose in the mother can cause glucotoxicity in the mother.“Glucotoxicity” refers to the toxic effect of glucose. Glucose is the main fuel for cell functions, but when it is high in the bloodstream, it causes toxicity to organs. Prevalence of GDM.The CDC reports mean prevenance of GDM is 6.9%. In U.S. mothers the prevenance increased from 6.0% in 2016 to 8.3% in 2021. Many different factors have played a role in increasing gestational diabetes in American mothers, some of those being the ongoing obesity epidemic with excess body weight being a known risk factor for insulin resistance. Another being advanced maternal age (AMA) as more American women have children later in life their body becomes less sensitive to insulin and requires a higher insulin output on top of the insulin that is required for the fetus. The “American diet” is also something that has a big effect in diabetes development. With the increase of high-carb foods that are readily available, the diet of Americans has declined and is affecting the metabolic health of mothers as they carry and deliver their children. Despite ongoing awareness of GDM, 6% to 9% of pregnant women in the United States are diagnosed with gestational diabetes, and the prevalence continues to increase worldwide. It is estimated that in 2017 18.4 million pregnancies were affected by GDM in the world, which then continued to increase to 1 in 6 births to women with GDM in 2019. It was also found that women living in low-income communities were disproportionately affected due to limited healthcare access. Additionally, women with GDM had a 1.4-fold increase in likelihood of undergoing a c-section, with 15% increase in risk of requiring blood transfusion. Screening for GDMGestational diabetes is screened between the 24th to 28th week of gestation in all women without known pregestational diabetes. In women who have high-risk for GDM the screening occurs during the first trimester, these women usually have at least one of the following: BMI > 30, prior history of GDM, known impaired glucose metabolism, and/or a strong family history of diabetes. The screening during the first trimester is to detect “pregestational diabetes” because we have to keep a good glycemic control to improve outcomes of pregnancy. So, if it's positive, you start treatment immediately. If these women are found to have a normal glucose, they repeat the testing again as done normally, at 24-28 weeks of gestation. How do we screen?The screening itself consists of two types of approaches. The two-step approach includes a 50-gram oral glucose tolerance test (OGTT), where blood glucose is measured in an hour and if it is below 140 they are considered to not have GDM, however if the reading is greater than 140 they must then do a 3-hour, 100g oral glucose tolerance test. The 3-hour OGTT includes measuring the blood sugars at Fasting which should be less than 95, at 1 hour at less than 180, at 2 hours at less than 155, and at 3 hours at less than 140. If 2 or more of these values exceed the threshold the patient is diagnosed with gestational diabetes mellitus. The one-step approach includes 75g after an overnight fast. Blood glucose is measured while fasting which should be less than 92, at 1 hour less than 180 and at 2 hours less than 153. If any one of these values is exceeded, the patient is diagnosed with GDM.If the mother is found to be GDM positive during pregnancy she will also need continued screening post-partum to monitor for any development of overt diabetes. The testing is usually 75g 2-hour OGTT at 6-12 weeks postpartum. If this testing is normal, then they are tested using HbA1c every 3 years. If the post-partum testing shows pre-diabetes, annual testing is recommended using HbA1c measurements. Maternal complications Women with GDM are at an increased risk for future cardiovascular disease, T2DM, and chronic kidney disease. GDM is also associated with increased likelihood of developing pre-eclampsia following delivery. Pre-eclampsia is a complication seen in pregnancy characterized by high blood pressure, proteinuria, vision changes, and liver involvement (high LFTs). Pre-eclampsia can then progress to eclampsia or HELLP syndrome, both of which can include end organ damage. Additionally, she can develop polyhydramnios which leads to overstretching of the uterus and can induce pre-term labor, placental abruption, and or uterine atony, all of which additionally put the mother at increased risk for c-section. All of these maternal complications that stem from GDM lead to complications and extended hospitalization. Child's complications Although there is an increased set of risks for the mother, the neonate can also develop a variety of risks due to the increased glucose while in utero. While the fetus is growing, the placenta is the source of nutrition for the fetus. As the levels of glucose in the mother increase so does the amount of glucose filtered through the placenta and into the fetal circulation. Over time the glucose leads to oxidative stress and inflammation with activation of TGF-b which leads to fibroblast activation and fibrosis of the placenta. This fibrosis decreases the nutrient and oxygen exchange for the fetus. As the fetus attempts to grow in this restrictive environment its development is affected. The fetus can develop IUGR (intrauterine growth restriction) leading to a small for gestation age newborn which can then lead to another set of complications. The low oxygen environment can lead to increased EPO production and polycythemia at birth which can then lead to increased clotting that can travel to the newborn brain. Newborns can also be born with fetal acidosis due to the anerobic metabolism and lactic acid buildup in fetal tissues which can cause fetal encephalopathy leading to cerebral palsy and developmental delay. And the most severe of newborn complications to gestational diabetes can lead to fetal demise. Furthermore, the increase of glucose can also lead to macrosomia in the infant which can often lead to a traumatic delivery and delivery complications such as shoulder dystocia and brachial plexus injury. Brachial plexus injury sometimes resolves without sequela, but other times can lead to permanent weakness or paralysis of the affected arm. The baby can be born too small or too big.Additionally, once the fetus is born the cutting of the umbilical cord leads to a rapid deceleration in blood glucose in the fetal circulation and hypoglycemic episodes can occur, that often lead to NICU admission. The insulin that is created by the fetus in utero to accommodate the large quantities of glucose is known to affect lung maturation as well. The insulin produced inhibits surfactant production in the fetus. Upon birth some of the newborns also have to be placed on PEEP for ventilation and some children require treatment with surfactant to prevent alveolar collapse and/or progression to NRDS created by the low surfactant levels. Additionally, neonates who are macrosomic, which is usually seen in GDM mothers, are larger and stronger and when put on PEEP to help increase ventilation the newborn's stronger respiratory effort can lead to higher pulmonary pressures and barotrauma such as neonatal pneumothorax.Long term complications to the child of a mother with GDM also occur. As the child grows, they are also at an increased risk for developing early onset obesity because of the increased adipose storage triggered by the increase in insulin in response to the high glucose in utero. This then can lead to a higher chance of developing type 2 diabetes mellitus in the child. With diabetes, also comes an increase in cardiovascular risk as the child ages and becomes an adult. The effects of GDM go beyond the fetal life but continue through adulthood.What can be done?Gestational Diabetes Mellitus has many severe and lifelong consequences for both the mother and the child and prevention of GDM would help enhance the quality of life of both. Many of the ways to prevent GDM complications include patient education and dietary modifications with a diet rich in whole grains, fruits, vegetables and lean proteins. Benefits of some vegetables in the Mexican cuisine that may be beneficial: Nopales, Chayote, and Jicama. Those are good alternatives for highly processed carbs.Mothers are usually offered nutritional counseling to help them develop a tailored eating plan. This and 30 minutes of moderate exercise daily is recommended to increase insulin sensitivity and lower the post-prandial glucose levels. If within 2 weeks of implementing lifestyle changes alone the glucose measurements remain high, then medications like insulin can be put onboard to manage the GDM. If they require insulin, I think it is time to refer to a higher level of care, if available, high risk OB clinic.Conclusion: Now we conclude episode number ###, “[TITLE].” [summary here]. _____________________References:Eades CE, Burrows KA, Andreeva R, Stansfield DR, Evans JM. Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Mar 15;24(1):204. doi: 10.1186/s12884-024-06378-2. PMID: 38491497; PMCID: PMC10941381. https://pubmed.ncbi.nlm.nih.gov/38491497/QuickStats: Percentage of Mothers with Gestational Diabetes,* by Maternal Age — National Vital Statistics System, United States, 2016 and 2021. Weekly / January 6, 2023 / 72(1);16. https://www.cdc.gov/mmwr/volumes/72/wr/mm7201a4.htm?utmAkinyemi OA, Weldeslase TA, Odusanya E, Akueme NT, Omokhodion OV, Fasokun ME, Makanjuola D, Fakorede M, Ogundipe T. Profiles and Outcomes of Women with Gestational Diabetes Mellitus in the United States. Cureus. 2023 Jul 4;15(7):e41360. doi: 10.7759/cureus.41360. PMID: 37546039; PMCID: PMC10399637. https://pmc.ncbi.nlm.nih.gov/articles/PMC10399637/?utmPerlman, J. M. (2006). Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics, 117(3), S28–S33.DOI: 10.1542/peds.2005-0620C.Low, J. A. (1997). Intrapartum fetal asphyxia: definition, diagnosis, and classification. American Journal of Obstetrics and Gynecology, 176(5), 957–959.DOI: 10.1016/S0002-9378(97)70609-0.Hallman, M., Gluck, L., & Liggins, G. (1985). Role of insulin in delaying surfactant production in the fetal lung. Journal of Pediatrics, 106(5), 786–790.DOI: 10.1016/S0022-3476(85)80227-0.Sweet, D. G., Carnielli, V., Greisen, G., et al. (2019). European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update. Neonatology, 115(4), 432–450.DOI: 10.1159/000499361.Raju, T. N. K., et al. (1999). Respiratory distress in term infants: when to suspect surfactant deficiency. Pediatrics, 103(5), 903–909.DOI: 10.1542/peds.103.5.903.Burns, C. M., Rutherford, M. A., Boardman, J. P., & Cowan, F. M. (2008). Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics, 122(1), 65–74.DOI: 10.1542/peds.2007-2822.Dabelea, D., et al. (2000). Long-term impact of maternal diabetes on obesity in childhood. Diabetes Care, 23(10), 1534–1540.DOI: 10.2337/diacare.23.10.1534.Dashe, J. S., et al. (2002). "Hydramnios: Etiology and outcome." Obstetrics & Gynecology, 100(5 Pt 1), 957–962.DOI: 10.1016/S0029-7844(02)02279-6.Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to prevent gestational diabetes mellitus: a decision-analytic modelling study. Diabetologia.American College of Obstetricians and Gynecologists. (2018). Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstetrics & Gynecology, 131(2), e49–e64. https://doi.org/10.1097/AOG.0000000000002501Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

On episode #81 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 5/8/25 – 5/21/25. Hosts: Daniel Griffin Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo (NEJM) Remdesivir associated with reduced mortality in hospitalized COVID-19 patients (BMC Infectious Diseases) Real-world evidence shows remdesivir tied to less death in hospitalized COVID patients (CIDRAP) Impact of most promising Ebola therapies on survival (Virology Journal) Bacterial Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams (CID) Diet and Risk for Incident Diverticulitis in Women (Annals of Internal Medicine) The Dynamics of QuantiFERON-TB Gold In-Tube Conversion and Reversion in a Cohort of South African Adolescents(American Journal of Respiratory and Critical Care Medicine) BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection(NEJM) The Impact of Diet on Clostridioides difficile Infection (JID) Cefazolin versus Antistaphylococcal Penicillins for the Treatment of Methicillin-Susceptible Staphylococcusaureus Bacteremia (CMI: Clinical Microbiology and Infection) Fungal The Last of US Season 2 (YouTube) Candida auris is emerging as a prevalent urinary pathogen (PLoS Pathgoens A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis (Science) Outcome predictors of Candida prosthetic joint infections (OFID) Cave-Associated Histoplasmosis Outbreak Among Travelers Returning from Costa Rica — Georgia, Texas, and Washington, December 2024–January 2025 (CDC: MMWR) Parasitic COPEG 25th Anniversary (US Embassy in Panama) USDA suspends southern border livestock imports over New World screwworm threat(CIDRAP) Moxidectin combination therapies for lymphatic filariasis (LANCET: Infectious Diseases Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Rutherford Pascal is a seasoned Sales Leader in the pharma industry. His 35-year career led him to increasingly Senior roles, most recently as Head of Sales at Sanofi for their Respiratory and Gastroenterology Specialty Care portfolio.Rutherford is passionate about leadership development and mentorship. For his next act, he launched Glass Walls Leadership in 2024. Rutherford is a certified John Maxwell Leadership Trainer, Coach and an inspirational keynoter, with his first book, "The P.I.D System," about to be published. As one of the most visible African-American sales leaders in his industry, Rutherford is committed to fostering diversity within his teams and the benefits of embracing a diverse workforce.https://www.amazon.com/P-I-D-System-Preparation-Intentionality-Differentiation/dp/B0F8BBB7KV

Part two identifies the different adjuncts used for intubation, some of the medications used for intubation and reversal, positioning and briefly touches on tracheostomy.

Tamsin Chislett, CEO of Hyfe, highlights the importance of understanding coughs for healthcare providers, the lack of information about coughs, and Hyfe's advancements in building a database and developing biomarkers based on different kinds of coughs. Hyfe's AI technology, which can integrate with other devices and platforms for remote patient monitoring, enables passive, continuous tracking of cough patterns that can be used in research and clinical trials. Opportunities for digital therapeutics include chronic cough, COPD, lung cancer, respiratory infections, and cardiovascular diseases.  Tamsin elaborates, "Hyfe is the global leader in AI power. The problem we're trying to solve is that you have this really common symptom cough, which has been experienced by every human alive and is experienced daily by many people, yet to discuss it, measure it, monitor it, or even manage it, we're entirely reliant on subjective data. Everyone's had the experience of going into a primary care doctor, and saying I've got a really bad cough. The doctor says How bad is it, and is it getting worse?  We don't even have the proper language to describe it." "We want to get to the point where, in those situations, the doctor can start to get objective data about the patient's cough patterns and use that instead. The way we see it is that there was a time when to measure fever, we put a hand on a patient's forehead. We hope that within a few years, thanks to Hyfe's technology, we should not be in the same position with cough. So we're always looking to have objective data." "I think the interesting thing about cough is that because it's never been measurable, it hasn't been studied anywhere near as much as it probably should have. And even in the first five years of Hyfe's life, we've seen an explosion in cough-related science now that it's possible to monitor coughs with a smartphone, a smart watch, or anything with a microphone running Hyfe's technology. We've seen exciting science across a whole range, many of which are intuitive when you start thinking about cough, acute cough is a big one and respiratory infections, but there's also chronic cough."  "There's also COPD, there's IPF, there's lung cancer, there are so many respiratory and even cardiology diseases where cough is a cardinal symptom, a really clear sign of exacerbation of disease or worsening. However, to date, it has not been able to be measured, and cough monitoring with Hyfe allows you to monitor cough over time, see patterns, and use those patterns to optimize patient care in the future." #HyfeAI #ChronicCough #HyfeDTx #DigitalHealth #AIinHealthcare #DigitalTherapeutics #MedAI #CoughMonitoring #RemotePatientMonitoring #HealthInnovation #RespiratoryAwareness #CoughAwareness #CoughScience #PatientCentricCare hyfe.com Listen to the podcast here

Tamsin Chislett, CEO of Hyfe, highlights the importance of understanding coughs for healthcare providers, the lack of information about coughs, and Hyfe's advancements in building a database and developing biomarkers based on different kinds of coughs. Hyfe's AI technology, which can integrate with other devices and platforms for remote patient monitoring, enables passive, continuous tracking of cough patterns that can be used in research and clinical trials. Opportunities for digital therapeutics include chronic cough, COPD, lung cancer, respiratory infections, and cardiovascular diseases.  Tamsin elaborates, "Hyfe is the global leader in AI power. The problem we're trying to solve is that you have this really common symptom cough, which has been experienced by every human alive and is experienced daily by many people, yet to discuss it, measure it, monitor it, or even manage it, we're entirely reliant on subjective data. Everyone's had the experience of going into a primary care doctor, and saying I've got a really bad cough. The doctor says How bad is it, and is it getting worse?  We don't even have the proper language to describe it." "We want to get to the point where, in those situations, the doctor can start to get objective data about the patient's cough patterns and use that instead. The way we see it is that there was a time when to measure fever, we put a hand on a patient's forehead. We hope that within a few years, thanks to Hyfe's technology, we should not be in the same position with cough. So we're always looking to have objective data." "I think the interesting thing about cough is that because it's never been measurable, it hasn't been studied anywhere near as much as it probably should have. And even in the first five years of Hyfe's life, we've seen an explosion in cough-related science now that it's possible to monitor coughs with a smartphone, a smart watch, or anything with a microphone running Hyfe's technology. We've seen exciting science across a whole range, many of which are intuitive when you start thinking about cough, acute cough is a big one and respiratory infections, but there's also chronic cough."  "There's also COPD, there's IPF, there's lung cancer, there are so many respiratory and even cardiology diseases where cough is a cardinal symptom, a really clear sign of exacerbation of disease or worsening. However, to date, it has not been able to be measured, and cough monitoring with Hyfe allows you to monitor cough over time, see patterns, and use those patterns to optimize patient care in the future." #HyfeAI #ChronicCough #HyfeDTx #DigitalHealth #AIinHealthcare #DigitalTherapeutics #MedAI #CoughMonitoring #RemotePatientMonitoring #HealthInnovation #RespiratoryAwareness #CoughAwareness #CoughScience #PatientCentricCare hyfe.com Download the transcript here

Host George Halford sits down with Gene Gant, who is the CEO of Eventa LLC. Eventa provides complex respiratory care, along with other services and is based in Livingston. Hear about Gene's life story and more! Listen To The Local Matters Podcast Today! News Talk 94.1

Send us a textInterprofessional perspectives on non-invasive respiratory support practices in extremely preterm infants: a Canadian survey.Martinez TA, Remmer E, Mardakis S, Leone M, Boyer J, Lv S, Beltempo M, Sant'Anna G, Shalish W.J Perinatol. 2025 Apr 12. doi: 10.1038/s41372-025-02291-4. Online ahead of print.PMID: 40221609As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode:On the medical mailbag we look at respiratory muscle training and the Breather device. Do you need to inhale hard to pump up your diaphragm to get more power to the pedals? Plus Michael Arashita joins us today to dive into the wild world of triathlons and nutrition, it's not all sunshine and rainbows. With a background that screams “overachiever” — think pre-med biochemistry and an MBA in healthcare — he's transitioned from pro triathlete to the mastermind behind Blanks Nutrition, a company that's literally taking the labels off traditional sports nutrition. Segments:[12:41]- Medical Mailbag: The Breather[33:56]- Interview: Michael Arishita Links@Swimmikerun on Instagram Michael's Website

In this reflective milestone episode, Cheri Dotterer, host of The Writing Glitch, celebrates the 100th episode by revisiting some of the standout moments from the past school year. From interviews with experts on dyslexia and dysgraphia to product reviews and real-world classroom insights, Cheri recaps the evolution of handwriting, learning disabilities, and educational innovations that have shaped Season 3. She also opens up about the future of the podcast—what's next and why listener feedback matters now more than ever. If you've ever found value in these episodes, this is the one to share, celebrate, and reflect on.

The cordyceps brain infection that turns humans into terrifying monsters in The Last of Us is something that already exists in our world. So is it time to start worrying about Clickers and other fungus zombies?We are going to cut right to the chase on this one: Cordyceps, the brain infecting fungus that causes people to mutate into increasingly grotesque zombies in The Last of Us video games and the HBO TV adaptation, is very real. Of this, there is no doubt, as you'll see in our episode and read below. But like any good sci-fi, horror, or fantasy storytelling, the secret isn't so much in how realistic something is, but in how it obeys its own rules in-story.After all, who the heck needs a story about a devastating pandemic that was exacerbated by global warming these days, right? It's not like sci-fi and horror have ever been used to illustrate real world issues before. Why not just let escapism be escapism and leave all this uncomfortable real world stuff out of it?In case you couldn't sense the sarcasm (Does it Fly? is a Roddenberry podcast after all, and it's not like Star Trek has ever been shy about taking our present moment to task via the denizens of the 23rd, 24th, and 25th centuries), the inherent realism of The Last of Us is an integral part of what makes it work. But it's far from the only reason we're so enamored with this disturbing sci-fi and horror hybrid. And that's where Hakeem and Tamara come inWatch the latest episode of Does it Fly? right here (and try not to eat any infected grain)...https://www.youtube.com/watch?v=h8141JQ_kesSUGGESTED VIEWING One of the best things about The Last of Us is that the show is 100% accessible for folks who have never played the video games. It's also, perhaps not coincidentally, one of the only truly great video game to screen adaptations we've ever seen. We based our conversation for this episode on the first season of the show, but if you've even watched the first two episodes, you can probably keep up. Oh, just watch the entire first season!For some additional fungus-induced “fun” we also recommend the brilliant 2016 sci-fi horror movie The Girl With All the Gifts, which mines some similarly terrifying themes as The Last of Us.And don't forget, The Last of Us season 2 just kicked off on HBO and MAX so what are you waiting for? Go get caught up! Who knows? This could just be something in our future…FURTHER READING Do you want to delve a little deeper into the facts, concepts, and stories Hakeem and Tamara referenced in today's episode? Of course you do! The Zombie Ants Are Already HereThe intricately orchestrated way this fungus takes over insect brains and makes them do their bidding sure does give us something to think about. Read more at National Geographic! Fortunately, it doesn't seem like we have to worry too much about this becoming a human issue…just yet.Fungal PathogensIt even sounds gross when we put it that way. The Last of Us is so dead-on with its depiction of global-warming induced fungal infections that no less than the Yale School of Medicine wrote about it.Respiratory vs. Fungal InfectionsWe usually don't associate the usual respiratory viruses with fungal infections. But this article asks…why not both?A Guide to Knowing and Loving Your Infected Fungus ZombiesProper care and feeding for their lifecycle is important. Not really…run! Read more here.WANT MORE FROM DOES IT FLY?Black Mirror is back with a brand new season on Netflix. Check out our episode on one of its most iconic episodes, “San Junipero” right here!Whether fungus zombies or otherwise, we do occasionally take a look at the scarier side of genre entertainment from time to time. Like our episode on werewolves, for example.FOLLOW US!Stay in the loop! Follow DoesItFly? on YouTube and TikTok and let us know what you think! Subscribe to Does It Fly? Pod: https://www.youtube.com/@doesitflypod?sub_confirmation=1And don't forget to follow Roddenberry Entertainment:Instagram: @RoddenberryOfficial Facebook: RoddenberryBluesky: @roddenberrypod.bsky.socialFor Advertising Inquiries: doesitfly@roddenberry.comCheck out the official Does it Fly? playlist, too!

In this episode of The ICHE Podcast, Editor-in-Chief David Calfee is joined by Drs. Catherine Passaretti and Michael Klompas for a timely discussion on healthcare-acquired respiratory viral infections (HA-RVIs). Together, they explore how frequently these infections occur, the primary sources of transmission—including infected healthcare personnel (HCP)—and the infection prevention strategies aimed at minimizing risk. Dr. Passaretti walks listeners through her recently published letter proposing updates to current HCP return-to-work guidelines following COVID-19 infection. She explains the rationale behind the proposal, citing key concerns with existing guidance. Dr. Klompas then discusses two papers: one by Stone et al., which investigates the impact of current return-to-work policies, and another by Klompas himself, which reflects on the broader implications and outlines additional strategies to reduce HCP-to-patient transmission risk. The episode concludes with actionable insights from each participant, offering practical steps that healthcare facilities can implement today to enhance respiratory virus prevention and reevaluate HCP return-to-work protocols based on evolving evidence and epidemiology. This conversation offers valuable guidance for healthcare leaders, infection preventionists, and policy makers navigating a post-COVID landscape.

Dr. Julie Siemers is a healthcare leader with 40+ years of experience who teaches people how to survive hospital stays and avoid becoming a statistic. New episodes of Welcome to Wellness every Friday!Not listening on Spotify? Show notes at: https://www.ashleydeeley.com/w2w/drjuliesiemersEpisode brought to you by: ApolloNeuroEpisode brought to you by:⁠⁠⁠⁠⁠⁠ VieLight⁠⁠⁠ - ⁠⁠⁠Code: DEELEY10Episode brought to you by:⁠⁠⁠⁠⁠⁠Dry Farm Wines⁠⁠⁠⁠⁠⁠ 8:57: Surviving Your Hospital Stay - book13:31:  Hospital Hierarchy: NurseCharge nurseHouse supervisorAdministrator14:59: CUSS words: Tell your nurse, "I feel..."ConcernedUncomfortableScaredSafety22:55: The 3 P'sBe presentBe politeBe persistent 24:39: Find the ranking of hospitals! https://www.hospitalsafetygrade.org/28:38: Patient left with a retractor insider her body30:48:  1 out of 4 Medicare patients that enter the hospital have some kind of harm happened to them34:35: Vital signsBlood pressure: normal is considered to be less than 120/80 mmHgHeart rate: normal resting heart rate is between 60 and 100 beats per minute (bpm)Respiratory rate: this is THE MOST SENSITIVE  and earliest indicator of patient deterioration; normal range is 12 to 20 breaths per minute 37:24: 80% of nurses don't count respiratory rate 38:51: Blood pressure cuff40:04: Opioids, Sleep Apnea, and Surgery44:11: The best thing to do if you need surgery - GET MOVINGIt boosts blood flow to your extremities, helping prevent deep vein thrombosis (DVT) or blood clots, which often start in the legs. It also supports lung expansion and overall circulation45:14: Invest in an  incentive spirometer (to ensure you have it after surgery)47:52: Symptoms of  low or high blood pressure, heart rate, respiratory issuesDizzyDehydratedTemperature irregularitiesHeart beat irregularities55:21: Protocol for a feeding tube58:08: Medication errors are a top problem in hospitals58:30: ALWAYS ask for test results/lab results/pathology reports1:02:59: Patient Safety Checklist1:04:33: Always double check that your name and patient details are correct on all forms, blood samples, etc.,1:08:28: Why Dr Siemers is against statins (as am I!)Where to find Dr. Julie Siemers⁠Website⁠InstagramFacebookYouTubeWhere to find Ashley Deeley:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠hello@ashleydeeley.com

Inside the Lab is joined by experts Drs. Hannah Wang from the Cleveland Clinic and Rodney Rohde from Texas State University to discuss emerging respiratory viruses. Their discussion begins with lessons learned from the COVID-19 pandemic and an overview of what technologies have emerged since. They go on to discuss the virology and surveillance strategies for H5N1 and RSV, as well as vaccine hesitancy and its impact in the treatment of measles. 

Episode 188: RSV Management and PreventionDr. Sandhu and future Dr. Mohamed summarize the management of RSV and describe how to prevent it with chemoprophylaxis and vaccines. Dr Arreaza adds some comments about RSV vaccines.Written by Abdolhakim Mohamed, MSIV, Ross University School of Medicine. Comments by Ranbir Sandhu, MD, and Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.What is RSV? -The Respiratory syncytial Virus (RSV) is an enveloped, negative-sense, single-stranded RNA virus of the Orthopneumovirus genus within the Pneumoviridae family. -RSV is a major cause of acute respiratory tract infections, particularly bronchiolitis and pneumonia, in infants and young children, and it also significantly affects older adults and immunocompromised individuals. -RSV infections cause an estimated 58,000–80,000 hospitalizations among children younger than 5 years and 60,000–160,000 hospitalizations among adults older than 65 years each year.-RSV is highly contagious and spreads through respiratory droplets and direct contact with contaminated surfaces. The virus typically causes seasonal epidemics, peaking in the winter months in temperate climates and during the rainy season in tropical regions. -Virtually all children are infected with RSV by the age of two, and reinfections can occur throughout life, often with milder symptoms.-Per the 2014 Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis, from the American Academy of Pediatrics, the most common etiology of bronchiolitis is RSV. -About 97% of children are infected with RSV in the first 2 years of life, about 40% will experience lower respiratory tract infection during the initial infection. Other viruses that cause bronchiolitis include human rhinovirus, human metapneumovirus, influenza, adenovirus, coronavirus, and parainfluenza viruses.When is RSV season?-Classically, the highest incidence of infection occurs between December and March in North America. Per CDC, there were typical prepandemic RSV season patterns, but the COVID-19 pandemic disrupted RSV seasonality during 2020–2022. -Before we dive into the seasonality patterns, for context, in order to describe RSV seasonality in the US, data was gathered and analyzed from polymerase chain reaction (PCR) test results reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) during July 2017–February 2023. -Seasonal RSV epidemics were defined as the weeks during which the percentage of PCR test results that were positive for RSV was ≥3%. Per 2017–2020 data, RSV epidemics in the United States typically follow seasonal patterns, that began in October, peaked in December or January, and ended in April. -However, during 2020–21, the typical winter RSV epidemic did not occur. The 2021–22 season began in May, peaked in July, and ended in January. -The 2022–23 season started (June) and peaked (November) later than the 2021–22 season, but earlier than prepandemic seasons. CDC notes that the timing of the 2022–23 season suggests that seasonal patterns are returning toward those observed in prepandemic years, however, warn that clinicians should be aware that off-season RSV circulation might continue.Treatment of RSVSome key points of the 2014 pediatric guidelines from the American Academy of Pediatrics.-AAP strongly do not recommend beta agonists or steroids for viral associated bronchiolitis because of no significant improved outcomes. “Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Strong Recommendation).”-Epinephrine is not recommended for infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Strong Recommendation).-Nebulized hypertonic saline should not be administered to infants with a diagnosis of bronchiolitis in the emergency department (Evidence Quality: B; Recommendation Strength: Moderate Recommendation), but hypertonic saline may be administered when they are hospitalized (Evidence Quality: B; Recommendation Strength: Weak Recommendation [based on randomized controlled trials with inconsistent findings]).-Chest physiotherapy should not be used in infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Moderate Recommendation).-Antibiotics should not be administered in bronchiolitis unless there is a concomitant bacterial infection, or a strong suspicion of one (Evidence Quality: B; Recommendation Strength: Strong Recommendation).-Oxygen therapy may not be administered if the oxyhemoglobin saturation exceeds 90% in infants and children with a diagnosis of bronchiolitis (Evidence Quality: D; Recommendation Strength: Weak Recommendation [based on low level evidence and reasoning from first principles]).-Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally (Evidence Quality: X; Recommendation Strength: Strong Recommendation).How do we prevent RSV?Infant Immuno-prophylaxis:A clinical trial in 2022 demonstrated that a single injection of nirsevimab (Beyfortus®), administered before the RSV season, protected healthy late-preterm and term infants from RSV-associated lower respiratory tract that required medical treatment. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an extended half-life.Additionally, on August 3, 2023, the Advisory Committee on Immunization Practices (ACIP) recommended nirsevimab for all infants younger than 8 months who are born during or entering their first RSV season and for infants and children between 8-19 months who are at increased risk for severe RSV disease and are entering their second RSV season. On the basis of pre-COVID-19 pandemic patterns, nirsevimab could be administered in most of the continental United States from October through the end of March.Maternal Vaccination: The CDC recommends the administration of the RSVPreF vaccine to pregnant women between 32 0/7 and 36 6/7 weeks of gestation. This vaccination aims to reduce the risk of RSV-associated lower respiratory tract infection in infants during the first 6 months of life.At this time, if a pregnant woman has already received a maternal RSV vaccine during any previous pregnancy, CDC does not recommend another dose of RSV vaccine during subsequent pregnancies.Older individuals: -Each year in the U.S., it is estimated that between 60,000 and 160,000 older adults are hospitalized and between 6,000 and 10,000 die due to RSV infection-ABRYSVO's approval will help offer older adults protection in the RSV season.-On June 26, 2024, ACIP voted to give these recommendations: all adults older than 75 years and adults between 60–74 years who are at increased risk for severe RSV disease should receive a single dose of RSV vaccine (Abrysvo®).Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Hamid S, Winn A, Parikh R, et al. Seasonality of Respiratory Syncytial Virus — United States, 2017–2023. MMWR Morb Mortal Wkly Rep 2023;72:355–361. DOI: http://dx.doi.org/10.15585/mmwr.mm7214a1Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275. PMID: 35235726.Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S 3rd, Hernandez-Cancio S; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742. Erratum in: Pediatrics. 2015 Oct;136(4):782. doi: 10.1542/peds.2015-2862. PMID: 25349312.CDC, per their published article Seasonality of Respiratory Syncytial Virus — United States for 2017–2023, in the United StatesWhat U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.Debessai H, Jones JM, Meaney-Delman D, Rasmussen SA. Obstetrics and Gynecology. 2024;143(3):e54-e62. doi:10.1097/AOG.0000000000005492.Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged

Maximizing absorption of supplements is important for optimizing health and our budget! Many companies are innovating on bioavailability and nobody is more cutting edge than Terry Naturally. On this episode of Vitality Radio, Jared invites Dr. Lexi Loch to the show to break down their GammaSorb technology for enhanced nutrient absorption. They discuss how it works and why it's important, and they delve into several of the products they are offering with GammaSorb. These products include Red Ginseng, Lactoferrin, Propolis, PEA, and Ivy Leaf Extract, covering men's and women's health, energy, immune support, pain management, and respiratory support.Terry Naturally Products:Red GinsengLactoferrin & Propolis ExtractPEABronchial Clear - Ivy Leaf ExtractVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

What does JJ the RT have to say about last episode's exploration of sedation and ventilator asynchrony? Are respiratory therapists prepared and empowered to optimize their role in Awake and Walking ICUs? How can create an environment that fosters RT excellence? JJ explores it all in this episode. Www.DaytonICUConsulting.com

On this "Outside Hospitalist" segment, Dr. Gabi Hester speaks with guest Dr. Courtney Herring, Pediatric Hospitalist, about evidence-based care of acute respiratory illnesses and nuances to consider in differently resourced settings.

For this episode we are joined by EBM guru, Dr. Brian Locke, who deftly breaks down all of our statistics questions. Is half dose DOAC as good as full dose DOAC for preventing VTE, and does it reduce bleeding risk? Can procalcitonin reduce duration of antibiotics for infections without compromising mortality rates? Can LLMs like GPT-4 help physicians manage patients better? Can reinforcement learning models predict when to start vasopressin in patients with septic shock? What is the risk of resuming anticoagulation in patients with atrial fibrillation and prior intracerebral hemorrhage? Is high flow nasal cannula as good as non-invasive ventilation for different types of respiratory failure? We answer all these questions and more!Half Dose DOAC for Long Term VTE Prevention (RENOVE)Biomarker-Guided Antibiotic Duration (ADAPT-Sepsis)GPT-4 Assistance for Physician PerformanceOptimal Vasopressin Initiation for Septic Shock (OVISS)DOACs for A fib after ICH (PRESTIGE-AF)High Flow Nasal Cannula vs NIV for Respiratory Failure (RENOVATE)Music from Uppbeat (free for Creators!): https://uppbeat.io/t/soundroll/dope License code: NP8HLP5WKGKXFW2R

Join us for On the Mission: Earth Day with Amy Cadora as we explore how Norwex is making a difference for the planet through sustainable solutions. Amy shares how the Safe Haven 5 can help reduce chemicals and waste in your home while making everyday cleaning safer. Tune in for practical tips on creating a healthier home and a greener future with Norwex! Stats Shared in Podcast: • Using just the 5 products in our Safe Haven 5 Set and water helps eliminate 80+ chemicals in your home. (Based on a comparison of Norwex Safe Haven 5 to 18 retail brand cleaning products, 2020.) • Regular use of chemical sprays has long-term impact on lung function decline, equivalent to smoking a pack of cigarettes a day. (American Journal of Respiratory and Critical Care Medicine | bit.ly/36XHLEo ) • 45 different chemicals have been identified in household dust. (Natural Resources Defense Council on.nrdc.org/3BBSm67) • Up to 85% of contaminants are brought indoors in the first 4 steps. The floors of your home can harbor pollutants, chemicals, dust and bacteria. (University of Georgia College of Family and Consumer Sciences | bit.ly/3i6hDO9) • The Superior Mop Starter System physically removes up to 99% of bacteria from a surface with only water when following proper care and use instructions. (https://nrwx.info/Mop)

Chris is in the hotseat and his patient is in respiratory distress and making alllll the sounds. How does Chris hold up to this onslaught of respiratory trouble? Vote on our Instagram at @ems2020podcast!

Perhaps it's no coincidence that an infusion of spinach leaves has evidently been used since ancient times to treat respiratory symptoms.